🚀 VC round data is live in beta, check it out!

Droga Raia Valuation Multiples

Discover revenue and EBITDA valuation multiples for Droga Raia and similar public comparables like Tsuruha Holdings, BrightSpring Health, MatsukiyoCocokara, Alibaba Health and more.

Droga Raia Overview

About Droga Raia

Raia Drogasil SA is a large retail drug store operator in Brazil. The company is engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines. Its brands include Impulso, Amplimed, HealthBit, Stix, 4Bio, Drogasil, Raia and others.


Founded

2011

HQ

Brazil

Employees

64.8K

Sectors

Financials (LTM)

Revenue: $9B
EBITDA: $674M

EV

$10B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Droga Raia Financials

Droga Raia reported last 12-month revenue of $9B and EBITDA of $674M.

In the same LTM period, Droga Raia generated $3B in gross profit, $674M in EBITDA, and $274M in net income.

Revenue (LTM)


Droga Raia P&L

In the most recent fiscal year, Droga Raia reported revenue of $8B and EBITDA of $679M.

Droga Raia expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Droga Raia forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$9BXXX$8BXXXXXXXXX
Gross Profit$3BXXX$2BXXXXXXXXX
Gross Margin30%XXX29%XXXXXXXXX
EBITDA$674MXXX$679MXXXXXXXXX
EBITDA Margin8%XXX8%XXXXXXXXX
EBIT Margin6%XXX6%XXXXXXXXX
Net Profit$274MXXX$262MXXXXXXXXX
Net Margin3%XXX3%XXXXXXXXX
Net Debt——$640MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Droga Raia Stock Performance

Droga Raia has current market cap of $8B, and enterprise value of $10B.

Market Cap Evolution


Droga Raia's stock price is $4.78.

See Droga Raia trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$10B$8B-1.8%XXXXXXXXX$0.15

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Droga Raia Valuation Multiples

Droga Raia trades at 1.1x EV/Revenue multiple, and 14.6x EV/EBITDA.

See valuation multiples for Droga Raia and 15K+ public comps

EV / Revenue (LTM)


Droga Raia Financial Valuation Multiples

As of March 14, 2026, Droga Raia has market cap of $8B and EV of $10B.

Equity research analysts estimate Droga Raia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Droga Raia has a P/E ratio of 30.5x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$8BXXX$8BXXXXXXXXX
EV (current)$10BXXX$10BXXXXXXXXX
EV/Revenue1.1xXXX1.2xXXXXXXXXX
EV/EBITDA14.6xXXX14.4xXXXXXXXXX
EV/EBIT19.7xXXX19.4xXXXXXXXXX
EV/Gross Profit3.8xXXX4.0xXXXXXXXXX
P/E30.5xXXX31.9xXXXXXXXXX
EV/FCF78.3xXXX82.7xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Droga Raia Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Droga Raia Margins & Growth Rates

Droga Raia's revenue in the last 12 month grew by 13%.

Droga Raia's revenue per employee in the last FY averaged $0.1M.

Droga Raia's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Droga Raia's rule of X is 39% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Droga Raia and other 15K+ public comps

Droga Raia Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth13%XXX12%XXXXXXXXX
EBITDA Margin8%XXX8%XXXXXXXXX
EBITDA Growth17%XXX13%XXXXXXXXX
Rule of 40—XXX20%XXXXXXXXX
Bessemer Rule of X—XXX39%XXXXXXXXX
Revenue per Employee—XXX$0.1MXXXXXXXXX
S&M Expenses to Revenue—XXX20%XXXXXXXXX
G&A Expenses to Revenue—XXX4%XXXXXXXXX
Opex to Revenue—XXX23%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Droga Raia Public Comps

See public comps and valuation multiples for other Pharmacies comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Tsuruha HoldingsXXXXXXXXXXXXXXXXXX
BrightSpring HealthXXXXXXXXXXXXXXXXXX
MatsukiyoCocokaraXXXXXXXXXXXXXXXXXX
Alibaba HealthXXXXXXXXXXXXXXXXXX
Clicks GroupXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Droga Raia M&A Activity

Droga Raia acquired XXX companies to date.

Last acquisition by Droga Raia was on XXXXXXXX, XXXXX. Droga Raia acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Droga Raia

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Droga Raia Investment Activity

Droga Raia invested in XXX companies to date.

Droga Raia made its latest investment on XXXXXXXX, XXXXX. Droga Raia invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Droga Raia

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Droga Raia

When was Droga Raia founded?Droga Raia was founded in 2011.
Where is Droga Raia headquartered?Droga Raia is headquartered in Brazil.
How many employees does Droga Raia have?As of today, Droga Raia has over 64K employees.
Is Droga Raia publicly listed?Yes, Droga Raia is a public company listed on B3.
What is the stock symbol of Droga Raia?Droga Raia trades under RADL3 ticker.
When did Droga Raia go public?Droga Raia went public in 1995.
Who are competitors of Droga Raia?Droga Raia main competitors are Tsuruha Holdings, BrightSpring Health, MatsukiyoCocokara, Alibaba Health.
What is the current market cap of Droga Raia?Droga Raia's current market cap is $8B.
What is the current revenue of Droga Raia?Droga Raia's last 12 months revenue is $9B.
What is the current revenue growth of Droga Raia?Droga Raia revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Droga Raia?Current revenue multiple of Droga Raia is 1.1x.
Is Droga Raia profitable?Yes, Droga Raia is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Droga Raia?Droga Raia's last 12 months EBITDA is $674M.
What is Droga Raia's EBITDA margin?Droga Raia's last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of Droga Raia?Current EBITDA multiple of Droga Raia is 14.6x.
What is the current FCF of Droga Raia?Droga Raia's last 12 months FCF is $125M.
What is Droga Raia's FCF margin?Droga Raia's last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Droga Raia?Current FCF multiple of Droga Raia is 78.3x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial